Literature DB >> 19032451

Clinicopathological comparison of the World Health Organization/Wotherspoon score to the Groupe d'Etude des Lymphomes de l'Adult grade for the post-treatment evaluation of gastric mucosa-associated lymphoid tissue lymphoma.

Eisuke Shiozawa1, Tomoko Norose, Kazuhiro Kaneko, Toshiko Yamochi-Onizuka, Masafumi Takimoto, Michio Imawari, Hidekazu Ota.   

Abstract

BACKGROUND AND AIM: The World Health Organization (WHO) has adopted criteria for the histological differential diagnosis of gastric extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (GML) based on the criteria proposed by Wotherspoon in 1993 (WHO/Wotherspoon score). These histological criteria are commonly used by pathologists for initial diagnoses, but have not been adopted uniformly for the post-treatment evaluation of GML. In 2003, the Groupe d'Etude des Lymphomes de l'Adult (GELA) proposed a new histological grading system (GELA grade) in preference to use of the WHO/Wotherspoon score for post-treatment evaluation. In the present study, we compared the WHO/Wotherspoon and GELA systems to examine which histological criterion is better for post-treatment evaluation.
METHODS: Fourteen cases of GML under long-term follow up were initially diagnosed according to the WHO criteria with detailed immunohistology, and were periodically evaluated with both histological criteria after anti-Helicobacter pylori treatment. They were also evaluated based on histological stromal changes accompanying the disappearance of lymphoma tissue.
RESULTS: The study showed strong similarities between the WHO/Wotherspoon and GELA systems and no clear advantage of either system for post-treatment evaluation. The GELA grade could not be used for the evaluation of changes in the degree of lymphoma infiltration from pre- to post-treatment because the four-item scale is not comparable with the formal six-point WHO/Wotherspoon scale. Stromal changes in the lamina propria, including an empty appearance and fibrosis, were correlated with lymphoma reduction after treatment and appear to be good indicators for post-treatment evaluation.
CONCLUSION: We propose the utilization of the WHO/Wotherspoon score accompanied by the assessment of stromal changes for the post-treatment evaluation of GML.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032451     DOI: 10.1111/j.1440-1746.2008.05639.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

1.  Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.

Authors:  Sally Yepes; Maria Mercedes Torres; Carlos Saavedra; Rafael Andrade
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

2.  Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.

Authors:  Katsuya Sugizaki; Akira Tari; Yasuhiko Kitadai; Ichiro Oda; Shotaro Nakamura; Tadashi Yoshino; Toshiro Sugiyama
Journal:  Helicobacter       Date:  2018-03-04       Impact factor: 5.753

3.  Management of Suspicious Mucosa-Associated Lymphoid Tissue Lymphoma in Gastric Biopsy Specimens Obtained during Screening Endoscopy.

Authors:  Hyo-Joon Yang; Seon Hee Lim; Changhyun Lee; Ji Min Choi; Jong In Yang; Su Jin Chung; Seung Ho Choi; Jong Pil Im; Sang Gyun Kim; Joo Sung Kim
Journal:  J Korean Med Sci       Date:  2016-04-27       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.